Abstract
Fluorometric quantitative tyrosine determination on dried-blood spots is the primary neonatal screening test used for tyrosinemia type I (HT) in the province of Quebec. Succinylacetone determination on these same spots is used as the complementary test when the tyrosine level is higher than a given threshold. This procedure has proved to be less discriminant over the past few years because of changes in newborn feeding and because of early discharge of newborns from the nursery. We have developed an enzyme-linked immunosorbent assay (ELISA) to measure the deficient enzyme in HT in dried-blood spots. Fumarylacetoacetase (FAH) (E.C.3.7.1.2) was measured retrospectively by an ELISA on 25 dried-blood samples from proven patients with HT and prospectively in 72,000 specimens received in the neonatal screening program. In this pilot project, FAH was measured first, and, if necessary, succinylacetone was determined as the complementary test. All 25 samples from proven patients and specimens from four other patients detected in the pilot study have shown almost complete absence of FAH in dried-blood samples. At a cutoff level of 12.5% of normal adult blood spotted on the same type of paper, only 30 other cases disclosed FAH levels low enough to warrant succinylacetone measurement but had no detectable succinylacetone. The false-positive rate is thus 1:2,400 with this primary ELISA. However, blood transfusion in newborns prior to blood collection on filter paper may yield false-negative tests, since FAH is present in erythrocytes of normal donors.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berger R., Van Faassen H., Taanman J. W., De Vries H., Agsteribbe E. Type I tyrosinemia: lack of immunologically detectable fumarylacetoacetase enzyme protein in tissues and cell extracts. Pediatr Res. 1987 Oct;22(4):394–398. doi: 10.1203/00006450-198710000-00005. [DOI] [PubMed] [Google Scholar]
- Engvall E., Perlmann P. Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol. 1972 Jul;109(1):129–135. [PubMed] [Google Scholar]
- Grenier A., Bélanger L., Laberge C. alpha1-Fetoprotein measurement in blood spotted on paper: discriminating test for hereditary tyrosinemia in neonatal mass screening. Clin Chem. 1976 Jul;22(7):1001–1004. [PubMed] [Google Scholar]
- Grenier A., Laberge C. A modified automated fluorometric method for tyrosine determination in blood spotted on paper: a mass screening procedure for tyrosinemia. Clin Chim Acta. 1974 Nov 20;57(1):71–75. doi: 10.1016/0009-8981(74)90179-x. [DOI] [PubMed] [Google Scholar]
- Grenier A., Lescault A., Laberge C., Gagné R., Mamer O. Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia. Clin Chim Acta. 1982 Aug 4;123(1-2):93–99. doi: 10.1016/0009-8981(82)90117-6. [DOI] [PubMed] [Google Scholar]
- Holme E., Lindblad B., Lindstedt S. Possibilities for treatment and for early prenatal diagnosis of hereditary tyrosinaemia. Lancet. 1985 Mar 2;1(8427):527–527. doi: 10.1016/s0140-6736(85)92132-4. [DOI] [PubMed] [Google Scholar]
- Hsiang H. H., Sim S. S., Mahuran D. J., Schmidt D. E., Jr Purification and properties of a diketo acid hydrolase from beef liver. Biochemistry. 1972 May 23;11(11):2098–2102. doi: 10.1021/bi00761a016. [DOI] [PubMed] [Google Scholar]
- Kvittingen E. A., Børresen A. L., Stokke O., van der Hagen C. B., Lie S. O. Deficiency of fumarylacetoacetase without hereditary tyrosinemia. Clin Genet. 1985 Jun;27(6):550–554. doi: 10.1111/j.1399-0004.1985.tb02039.x. [DOI] [PubMed] [Google Scholar]
- Kvittingen E. A., Halvorsen S., Jellum E. Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia. Pediatr Res. 1983 Jul;17(7):541–544. doi: 10.1203/00006450-198307000-00005. [DOI] [PubMed] [Google Scholar]
- Lindblad B., Lindstedt S., Steen G. On the enzymic defects in hereditary tyrosinemia. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4641–4645. doi: 10.1073/pnas.74.10.4641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nicole L. M., Valet J. P., Laberge C., Tanguay R. M. Purification of mRNA coding for the enzyme deficient in hereditary tyrosinemia, fumarylacetoacetate hydrolase. Biochem Cell Biol. 1986 May;64(5):489–493. doi: 10.1139/o86-068. [DOI] [PubMed] [Google Scholar]